1971
DOI: 10.1111/j.1365-2141.1971.tb02724.x
|View full text |Cite
|
Sign up to set email alerts
|

The Measurement of Reticuloendothelial Iron Release using Iron–Dextran

Abstract: An index of reticuloendothelial cell release of iron for erythropoiesis can be derived from simultaneous measurements of iron—dextran and transferrin‐bound iron utilization. Reticuloendothelial iron release was found to be reduced in patients with Hodgkins disease, chronic renal failure and some cases of rheumatoid arthritis. It was increased in patients with iron deficiency.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

1974
1974
2008
2008

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 72 publications
(10 citation statements)
references
References 9 publications
0
10
0
Order By: Relevance
“…Extent and rate of response to intravenous iron in patients with progressive chronic renal failure may depend on the amount of residual glomerular filtration, and thus the responsiveness may diminish as the patients progressively loose renal function [12, 30]. In fact, continued administration of parenteral iron in some patients with advanced chronic renal failure may fail to increase their hematocrit [12], thereby risking iron overload.…”
Section: Response To Therapymentioning
confidence: 99%
See 3 more Smart Citations
“…Extent and rate of response to intravenous iron in patients with progressive chronic renal failure may depend on the amount of residual glomerular filtration, and thus the responsiveness may diminish as the patients progressively loose renal function [12, 30]. In fact, continued administration of parenteral iron in some patients with advanced chronic renal failure may fail to increase their hematocrit [12], thereby risking iron overload.…”
Section: Response To Therapymentioning
confidence: 99%
“…Factors that determine the rate of release of iron-dextran from macrophages in patients with iron deficiency are not well known [9, 30, 35, 40, 41, 42]. Release of iron from macrophages slows after the initial 2–3 weeks following iron-dextran injection despite persistent anemia [9, 35].…”
Section: Pharmacokineticsmentioning
confidence: 99%
See 2 more Smart Citations
“…In chronic in¯ammatory diseases, iron retention is increased by the mononuclear phagocyte system [29,30] and iron utilization is impaired secondary to decreased iron uptake by erythroblasts [31]. As shown in Table 3, ESR was higher in the iron nondepleted subgroup than in``iron depleted.''…”
Section: Discussionmentioning
confidence: 95%